Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …

Simple Summary Sinonasal squamous cell carcinomas are a group of diverse tumors
affecting the nasal cavity and paranasal sinuses. As a direct consequence of their rarity and …

Proton therapy has recently gained substantial momentum worldwide due to improved
accessibility to the technology and sustained interests in its advantage of better tissue …

Purpose Unresectable, locally advanced sinonasal epithelial tumours are rare diseases with
poor prognosis. Multimodal approach is widely used, although no standard therapy has …

Simple Summary SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare but locally
aggressive malignancy which usually presents very late with invasion into the orbits and …

Local and regional recurrences are common following an initial course of radiotherapy, yet
management of these recurrences remains a challenge. Reirradiation may be an optimal …

Indications to endoscopic surgery for sinonasal cancer have plateaued and are unlikely to
further expand. Endoscopic surgery provides noninferior results compared to open surgery …

Purpose To demonstrate temporal lobe necrosis (TLN) rate and clinical/dose-volume factors
associated with TLN in radiation-naïve patients with head and neck cancer treated with …

The aim of this study is to compare the effectiveness of carbon ion radiation therapy (CIRT),
proton radiation therapy (PRT), and photon‐based intensity‐modulated radiation therapy …